Products Categories
CAS No.: | 16488-48-5 |
---|---|
Name: | 2-(4-butylaminobenzoyl)oxyethyl-diethyl-azanium chloride |
Molecular Structure: | |
Formula: | C17H28 N2 O2 . Cl H |
Molecular Weight: | 328.93 |
Synonyms: | Benzoicacid, 4-(butylamino)-, 2-(diethylamino)ethyl ester, monohydrochloride (9CI);Benzoic acid, p-(butylamino)-, 2-(diethylamino)ethyl ester, monohydrochloride(8CI); Depolipon; Farmodent; Neodent Green; T-Cain; Teecaine |
Density: | g/cm3 |
Boiling Point: | 416.7°Cat760mmHg |
Flash Point: | 205.8°C |
Safety: | Poison by ingestion, subcutaneous, intravenous, and intraperitoneal routes. When heated to decomposition it emits toxic fumes of NOx and HCl. See also AMINES and ESTERS. |
PSA: | 41.57000 |
LogP: | 4.27220 |
What can I do for you?
Get Best Price
IUPAC Name: 2-[4-(Butylamino)benzoyl]oxyethyl-diethylazanium chloride
Synonyms of p-(Butylamino)benzoic acid-2-(diethyl amino)ethyl ester monohydro-chloride (CAS NO.16488-48-5) : 2-(Diethylamino)ethyl 4-(Butylamino)benzoate Hydrochloride ; p-Butylaminobenzoic Acid 2-(Diethylamino)ethyl Ester Monohydrochloride ; Benzoic acid, p-butylamino-, 2-(diethylamino)ethyl ester, monohydrochloride ; Calvital liquid ; p-Butylaminobenzoic acid, 2-(diethylamino)ethyl ester, monohydrochloride
CAS NO: 16488-48-5
Molecular Formula:C17H29ClN2O2
Molecular Weight :328.8774
Molecular Structure :
Flash Point: 205.8 °C
Enthalpy of Vaporization: 67 kJ/mol
Boiling Point: 416.7 °C at 760 mmHg
Vapour Pressure: 3.75E-07 mmHg at 25°C
p-(Butylamino)benzoic acid-2-(diethyl amino)ethyl ester monohydro-chloride (CAS NO.16488-48-5) is used as intermediate in organic synthesis.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 31500ug/kg (31.5mg/kg) | Drugs in Japan Vol. -, Pg. 829, 1990. | |
mouse | LD50 | intravenous | 4900ug/kg (4.9mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 413, 1975. |
mouse | LD50 | oral | 156mg/kg (156mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 413, 1975. |
mouse | LD50 | subcutaneous | 19100ug/kg (19.1mg/kg) | Drugs in Japan Vol. -, Pg. 829, 1990. | |
rabbit | LD50 | intravenous | 2400ug/kg (2.4mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 413, 1975. |
rat | LD50 | intraperitoneal | 20500ug/kg (20.5mg/kg) | Drugs in Japan Vol. -, Pg. 829, 1990. | |
rat | LD50 | intravenous | 4mg/kg (4mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 1, Pg. 218, 1951. | |
rat | LD50 | subcutaneous | 22500ug/kg (22.5mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 413, 1975. |